Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: Evidence for a common pathogenesis

Genes Chromosomes and Cancer

Volumn 53, Issue 9, 2014, Pages 779-787

  Agaram, Narasimhan P ^a   Chen, Chun Liang ^a   Zhang, Lei ^a   Laquaglia, Michael P ^a   Wexler, Leonard ^a   Antonescu, Cristina R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MDM2 PROTEIN, HUMAN; MYOD PROTEIN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN; NCOA2 PROTEIN, HUMAN; NUCLEAR RECEPTOR COACTIVATOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; PROTEIN MDM2;

ADOLESCENT; ADULT; AGED; CHILD; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; PRESCHOOL CHILD; RHABDOMYOSARCOMA; SCLEROSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; MYOD PROTEIN; NUCLEAR RECEPTOR COACTIVATOR 2; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-MDM2; RHABDOMYOSARCOMA; RHABDOMYOSARCOMA, EMBRYONAL; SCLEROSIS; YOUNG ADULT;

EID: 84904332096     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22187     Document Type: Article

References (22)

1. Anand G, Shapiro DN, Dickman PS, Prochownik EV. 1994. Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors. J Clin Invest 93:5-9.
2. Antonescu CR, Sommer G, Sarran L, Tschernyavsky SJ, Riedel E, Woodruff JM, Robson M, Maki R, Brennan MF, Ladanyi M, DeMatteo RP, Besmer P. 2003. Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin Cancer Res 9:3329-3337.
3. Bouron-Dal Soglio D, Rougemont AL, Absi R, Barrette S, Montpetit A, Fetni R, Fournet JC. 2009. SNP genotyping of a sclerosing rhabdomyosarcoma: Reveals highly aneuploid profile and a specific MDM2/HMGA2 amplification. Hum Pathol 40:1347-1352.
4. Cavazzana AO, Schmidt D, Ninfo V, Harms D, Tollot M, Carli M, Treuner J, Betto R, Salviati G. 1992. Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol 16:229-235.
5. Chiles MC, Parham DM, Qualman SJ, Teot LA, Bridge JA, Ullrich F, Barr FG, Meyer WH, Soft Tissue Sarcoma Committee of the Children's Oncology Group. 2004. Sclerosing rhabdomyosarcomas in children and adolescents: A clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Pediatr Dev Pathol 7:583-594.
6. Debiec-Rychter M, Hagemeijer A, Sciot R. 2003. Spindle-cell rhabdomyosarcoma with 2q36 approximately q37 involvement. Cancer Genet Cytogenet 140:62-65.
7. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. 2013. WHO Classification of Tumours of Soft Tissue and Bone. Lyon: IARC.
8. Folpe AL, McKenney JK, Bridge JA, Weiss SW. 2002. Sclerosing rhabdomyosarcoma in adults: Report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol 26:1175-1183.
9. Gil-Benso R, Carda-Batalla C, Navarro-Fos S, Pellin-Perez A, Llombart-Bosch A. 1999. Cytogenetic study of a spindle-cell rhabdomyosarcoma of the parotid gland. Cancer Genet Cytogenet 109:150-153.
10. Ho RH, Johnson J, Dev VG, Whitlock JA. 2004. A novel t(2;20)(q35;p12) in embryonal rhabdomyosarcoma. Cancer Genet Cytogenet 151:73-77.
11. Kikuchi K, Wettach GR, Ryan CW, Hung A, Hooper JE, Beadling C, Warrick A, Corless CL, Olson SB, Keller C, Mansoor A. 2013. MDM2 amplification and PI3KCA mutation in a case of sclerosing rhabdomyosarcoma. Sarcoma 2013:520858.
12. Leuschner I, Newton WA, Jr., Schmidt D, Sachs N, Asmar L, Hamoudi A, Harms D, Maurer HM. 1993. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region. A report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 17:221-230.
13. Mentzel T. 2010. Spindle cell rhabdomyosarcoma in adults: A new entity in the spectrum of malignant mesenchymal tumors of soft tissues. Pathologe 3:91-96.
14. Mentzel T, Katenkamp D. 2000. Sclerosing, pseudovascular rhabdomyosarcoma in adults. Clinicopathological and immunohistochemical analysis of three cases. Virchows Arch 436:305-311.
15. Mentzel T, Kuhnen C. 2006. Spindle cell rhabdomyosarcoma in adults: Clinicopathological and immunohistochemical analysis of seven new cases. Virchows Arch 449:554-560.
16. Mosquera JM, Sboner A, Zhang L, Kitabayashi N, Chen CL, Sung YS, Wexler LH, LaQuaglia MP, Edelman M, Sreekantaiah C, Rubin MA, Antonescu CR. 2013. Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes Chromosomes Cancer 52:538-550.
17. Nascimento AF, Fletcher CD. 2005. Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol 29:1106-1113.
18. Rubin BP, Hasserjian RP, Singer S, Janecka I, Fletcher JA, Fletcher CD. 1998. Spindle cell rhabdomyosarcoma (so-called) in adults: Report of two cases with emphasis on differential diagnosis. Am J Surg Pathol 22:459-464.
19. Shukla N, Ameur N, Yilmaz I, Nafa K, Lau CY, Marchetti A, Borsu L, Barr FG, Ladanyi M. 2012. Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways. Clin Cancer Res 18:748-757.
20. Szuhai K, de Jong D, Leung WY, Fletcher CD, Hogendoorn PC. 2014. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. J Pathol 232:300-307.
21. Van Antwerp ME, Chen DG, Chang C, Prochownik EV. 1992. A point mutation in the MyoD basic domain imparts c-Myc-like properties. Proc Natl Acad Sci USA 89:9010-9014.
22. Zambrano E, Perez-Atayde AR, Ahrens W, Reyes-Mugica M. 2006. Pediatric sclerosing rhabdomyosarcoma. Int J Surg Pathol 14:193-199.